At their meeting at the end of January 2024 the Heads of HTA Agencies issued a statement highlighting areas of particular interest for HTA in the revised Pharmaceutical Legislation for the European Union. See full statement here
At their meeting at the end of January 2024 the Heads of HTA Agencies issued a statement highlighting areas of particular interest for HTA in the revised Pharmaceutical Legislation for the European Union. See full statement here